Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gardulf

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Prevalence of Borrelia burgdorferi sensu lato infection in Ixodes ricinus in SwedenR Gustafson, T G Jaenson, A Gardulf, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2005
Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyU Nicolay, S Haag, F Eichmann, et al.
Immunological Reviews|June 1, 1994
Systemic and topical immunoglobulin treatment in immunocompromised patientsL Hammarström, A Gardulf, V Hammarström, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 12, 2013
Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQLG H Jörgensen, A Gardulf, M I Sigurdsson, et al.
Clinical and Experimental Immunology|March 18, 2008
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficienciesR Gustafson, A Gardulf, S Hansen, et al.
Clinical and Experimental Immunology|November 12, 2014
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency diseaseS Jolles, J S Orange, A Gardulf, et al.
Journal of Clinical Immunology|February 8, 2013
Clinical symptoms in adults with selective IgA deficiency: a case-control studyG H Jorgensen, A Gardulf, M I Sigurdsson, et al.
Lancet (London, England)|February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsA Gardulf, V Andersen, J Björkander, et al.
Journal of Advanced Nursing|May 1, 1995
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapyA Gardulf, H Björvell, V Andersen, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Prevalence of Borrelia burgdorferi sensu lato infection in Ixodes ricinus in SwedenR Gustafson, T G Jaenson, A Gardulf, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2005
Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyU Nicolay, S Haag, F Eichmann, et al.
Immunological Reviews|June 1, 1994
Systemic and topical immunoglobulin treatment in immunocompromised patientsL Hammarström, A Gardulf, V Hammarström, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 12, 2013
Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQLG H Jörgensen, A Gardulf, M I Sigurdsson, et al.
Clinical and Experimental Immunology|March 18, 2008
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficienciesR Gustafson, A Gardulf, S Hansen, et al.
Clinical and Experimental Immunology|November 12, 2014
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency diseaseS Jolles, J S Orange, A Gardulf, et al.
Journal of Clinical Immunology|February 8, 2013
Clinical symptoms in adults with selective IgA deficiency: a case-control studyG H Jorgensen, A Gardulf, M I Sigurdsson, et al.
Lancet (London, England)|February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsA Gardulf, V Andersen, J Björkander, et al.
Journal of Advanced Nursing|May 1, 1995
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapyA Gardulf, H Björvell, V Andersen, et al.
Pageof 4